Evaluation of Intermittent Hemodialysis in Critically Ill Cancer Patients with Acute Kidney Injury Using Single-Pass Batch Equipment

Imagem de Miniatura
Arquivos
art_SILVA_Evaluation_of_Intermittent_Hemodialysis_in_Critically_Ill_Cancer_2016.PDF (272.45 KB)
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2016
Editora
PUBLIC LIBRARY SCIENCE
DOI
Indexadores
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Autores
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
PLOS ONE, v.11, n.3, article ID e0149706, 16p, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Data on renal replacement therapy (RRT) in cancer patients with acute kidney injury (AKI) in the intensive care unit (ICU) is scarce. The aim of this study was to assess the safety and the adequacy of intermittent hemodialysis (IHD) in critically ill cancer patients with AKI. Methods and Findings In this observational prospective cohort study, 149 ICU cancer patients with AKI were treated with 448 single-pass batch IHD procedures and evaluated from June 2010 to June 2012. Primary outcomes were IHD complications (hypotension and clotting) and adequacy. A multiple logistic regression was performed in order to identify factors associated with IHD complications (hypotension and clotting). Patients were 62.2 +/- 14.3 years old, 86.6% had a solid cancer, sepsis was the main AKI cause (51%) and in-hospital mortality was 59.7%. RRT session time was 240 (180-300) min, blood/dialysate flow was 250 (200-300) mL/min and UF was 1000 (0-2000) ml. Hypotension occurred in 25% of the sessions. Independent risk factors (RF) for hypotension were dialysate conductivity (each ms/cm, OR 0.81, CI 0.69-0.95), initial mean arterial pressure (each 10 mmHg, OR 0.49, CI 0.40-0.61) and SOFA score (OR 1.16, CI 1.03-1.30). Clotting and malfunctioning catheters (MC) occurred in 23.8% and 29.2% of the procedures, respectively. Independent RF for clotting were heparin use (OR 0.57, CI 0.33-0.99), MC (OR 3.59, CI 2.24-5.77) and RRT system pressure increase over 25% (OR 2.15, CI 1.61-4.17). Post RRT blood tests were urea 71 (49-104) mg/dL, creatinine 2.71 (2.10-3.8) mg/dL, bicarbonate 24.1 (22.5-25.5) mEq/L and K 3.8 (3.5-4.1) mEq/L. Conclusion IHD for critically ill patients with cancer and AKI offered acceptable hemodynamic stability and provided adequate metabolic control.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/13897
Referências
  1. Maccariello E, 2011, NEPHROL DIAL TRANSPL, V26, P537, DOI 10.1093/ndt/gfq441
  2. Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507
  3. Lameire N, 2008, CURR OPIN CRIT CARE, V14, P635, DOI 10.1097/MCC.0b013e32830ef70b
  4. Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P785, DOI 10.1093/ndt/gfh102
  5. Azoulay E, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-5
  6. Soares M, 2010, CRIT CARE MED, V38, P9, DOI 10.1097/CCM.0b013e3181c0349e
  7. Fiaccadori E, 2013, CLIN J AM SOC NEPHRO, V8, P1670, DOI 10.2215/CJN.00510113
  8. Lombardi R, 2014, NEPHROL DIAL TRANSPL, V29, P1369, DOI 10.1093/ndt/gfu078
  9. Berbece AN, 2006, KIDNEY INT, V70, P963, DOI 10.1038/sj.ki.5001700
  10. Hosmer DW, 1997, STAT MED, V16, P965
  11. Soares M, 2006, J CLIN ONCOL, V24, P4003, DOI 10.1200/JCO.2006.05.7869
  12. Hajjar LA, 2011, CLINICS, V66, P2037, DOI 10.1590/S1807-59322011001200007
  13. Dhondt A, 2010, ARTIF ORGANS, V34, P1132, DOI 10.1111/j.1525-1594.2009.00981.x
  14. Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751
  15. Falanga A, 2014, CURR OPIN HEMATOL, V21, P423, DOI 10.1097/MOH.0000000000000072
  16. Fiaccadori E, 2007, NEPHROL DIAL TRANSPL, V22, P529, DOI 10.1093/ndt/gfl627
  17. Eloot S, 2007, NEPHROL DIAL TRANSPL, V22, P2962, DOI 10.1093/ndt/gfm356
  18. Fassbinder W, 2003, KIDNEY BLOOD PRESS R, V26, P96, DOI 10.1159/000070990
  19. Benoit DD, 2005, NEPHROL DIAL TRANSPL, V20, P552, DOI 10.1093/ndt/gfh637
  20. Ruka W, 2001, ANN ONCOL, V12, P1423, DOI 10.1023/A:1012527006566
  21. HANLEY JA, 1982, RADIOLOGY, V143, P29
  22. Schortgen F, 2000, AM J RESP CRIT CARE, V162, P197
  23. Koyner JL, 2014, AM J KIDNEY DIS, V64, P394, DOI 10.1053/j.ajkd.2014.03.018
  24. Lecuyer L, 2007, CRIT CARE MED, V35, P808, DOI 10.1097/01.CCM.0000256846.27192.7A
  25. Salahudeen AK, 2009, CLIN J AM SOC NEPHRO, V4, P1338, DOI 10.2215/CJN.02130309
  26. Darmon M, 2007, INTENS CARE MED, V33, P765, DOI 10.1007/s00134-007-0579-1
  27. DAUGIRDAS JT, 1994, AM J KIDNEY DIS, V23, P33
  28. Darmon M, 2006, CRIT CARE, V10, DOI 10.1186/cc4907
  29. Falanga A, 2015, THORMB RES S, V1, pS8
  30. Fieghen HE, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-32
  31. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT S, V3, P1, DOI 10.1038/KISUP.2012.73
  32. Levy MM, 2001, CRIT CARE MED, V2003, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B
  33. Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713
  34. Park MR, 2011, J CRIT CARE, V26, P107
  35. Pertosa G, 2000, KIDNEY INT, V58, pS104
  36. Ponce D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081697
  37. Schwenger V, 2012, CRIT CARE, V16, DOI 10.1186/cc11445
  38. Taccone FS, 2009, CRIT CARE, V13, DOI 10.1186/cc7713

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/08
Artigos e Materiais de Revistas Científicas - LIM/12
Carregar mais